Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn&rsquo;s disease patients

doi:10.3748/wjg.v19.i17.2676

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 17

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6291)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

372

HTML

3309

Figures (1-2)

221

Tables (1-2)

124

Sum=4026

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1103

Download

1162

Sum=2265

May 7, 2013 (publication date) through May 2, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 7, 2013; 19(17): 2676-2682
Published online May 7, 2013. doi: 10.3748/wjg.v19.i17.2676

Full Size Figure Download Figure

Figure 1 Clinical remission rate. Combinational therapy with adalimumab and azathioprine significantly increased the clinical remission rate vs nonconcomitant use at week 24.

Citation: Ishida K, Inoue T, Fujiwara K, Sakanaka T, Narabayashi K, Nouda S, Okada T, Kakimoto K, Kuramoto T, Kawakami K, Abe Y, Takeuchi T, Murano M, Tokioka S, Umegaki E, Higuchi K. Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn’s disease patients. World J Gastroenterol 2013; 19(17): 2676-2682
URL: https://www.wjgnet.com/1007-9327/full/v19/i17/2676.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i17.2676